BCR-ABL-IN-1是一种BCR-ABL酪氨酸激酶抑制剂,pIC50值为6.46,可能用于慢性髓细胞白血病的研究。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
BCR-ABL-IN-1 is an inhibitor of BCR-ABL tyrosine kinase, with a pIC50 of 6.46, and may be used in the research of chronic myelogenous leukemia.
BCR-ABL-IN-1 (Compound 21) is an inhibitor of BCR-ABL tyrosine kinase, with a pIC50 of 6.46, and may be used in the research of chronic myelogenous leukemia.
[1]. Cui J1, et al. BCR-ABL tyrosine kinase inhibitor pharmacophore model derived from a series of phenylaminopyrimidine-based (PAP) derivatives. Bioorg Med Chem Lett. 2013 Apr 15;23(8):2442-50.
Glycolic acid oxidase inhibitor 1
¥1210.00 ¥1512.00
没有评价数据